methylbenzethonium chloride

CAS: 25155-18-4 C28 H44 Cl N O2 MW: 462.11608000

Identification

Namemethylbenzethonium chloride
CAS Number25155-18-4
EINECS246-675-7
FDA UNII4XKK0M5H9M
Molecular FormulaC28 H44 Cl N O2
Molecular Weight462.11608000
MDL NumberMFCD00011821

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Flash Point 32.00 °F. TCC ( 0.00 °C. ) (est)
Soluble in water, 0.1643 mg/L @ 25 °C (est)

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesantimicrobial agents

No sensory data available

Safety Information

Preferred SDSView
Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categoryantimicrobial, antistatic agents
Recommendation for methylbenzethonium chloride usage levels up tonot for fragrance use.
Recommendation for methylbenzethonium chloride flavor usage levels up tonot for flavor use.

BOC Sciences

Best of Chemicals Supplier

Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...

View All Website 1-631-485-4226 account@bocsci.com

Glentham Life Sciences Ltd

The Chemical, Biochemical & Research Essentials Supplier

Glentham Life Sciences is a supplier of fine chemicals and raw materials with warehousing, laboratories and packaging facilities in the UK.

View All Website +44 (0) 1225 667798 info@glentham.com

Potential Uses

antimicrobial agents antistatic agents deodorants surfactants

Natural Occurrence

not found in nature

Synonyms

benzyl-dimethyl-[2-[2-[2-methyl-4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride methyl benzethonium chloride PubMed: Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening. PubMed: Interventions for American cutaneous and mucocutaneous leishmaniasis. PubMed: Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials. PubMed: Interventions for Old World cutaneous leishmaniasis. PubMed: Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod. PubMed: Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. PubMed: Occupational allergic contact dermatitis from alkylammonium amidobenzoate. PubMed: Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study. PubMed: Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. PubMed: Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. PubMed: Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. PubMed: Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate. PubMed: [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)]. PubMed: Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. PubMed: Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study. PubMed: Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana. PubMed: Leishmania major: bacterial contamination of cutaneous lesions in experimental animals. PubMed: Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. PubMed: Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment. PubMed: Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin. PubMed: Leishmania major: histopathological responses before and after topical treatment in experimental animals. PubMed: Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment. PubMed: Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals. PubMed: Leishmania major: antileishmanial activity of methylbenzethonium chloride. PubMed: Topical treatment of cutaneous leishmaniasis. PubMed: Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy. PubMed: Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride. PubMed: Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals. PubMed: Studies on the local treatment of wounds for the prevention of rabies. PubMed: The prevention and treatment of seborrhea capitis with an antibacterial emulsion containing methylbenzethonium chloride. PubMed: ADDITIONAL uses of methylbenzethonium chloride. PubMed: Methylbenzethonium chloride in the care of skin of infants and children. PubMed: NEW and nonofficial remedies; methylbenzethonium chloride.